Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VELOS-1: Tanfanercept in Dry Eye
NCT03334539Phase 2Completed
- Sponsor
- HanAll Biopharma
- Start
- Nov 2017
- Primary completion
- Apr 2018
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of tanfanercept in dry eye disease (DED), sponsored by HanAll Biopharma. Started Nov 2017; status: completed.
02
Drugs
tanfanercept
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03334539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03334539.